Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Ltd ( (AU:MEM) ) has shared an update.
Memphasys Ltd has announced the issuance of 45,115,338 unquoted securities, specifically options expiring on November 5, 2026. This move is part of previously announced transactions and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests.
More about Memphasys Ltd
Memphasys Ltd operates in the biotechnology industry, focusing on reproductive biotechnology solutions. The company is known for developing products that enhance fertility outcomes, targeting both clinical and consumer markets.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.46M
See more insights into MEM stock on TipRanks’ Stock Analysis page.